These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice]. Farzad M, De Luca MC, Rubino G, Pirtoli L, Pepi F, Sebaste L, Ponticelli P, Atzeni G, Maranzano E, Silvano G. Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442 [Abstract] [Full Text] [Related]
3. [Follow-up study of clinical effects of californium-252 neutron intracavitary radiotherapy and external beam radiotherapy in endometrial cancer]. Lei X, Shan JL, Tang C, Zhao KW. Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):733-6. PubMed ID: 18307897 [Abstract] [Full Text] [Related]
5. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Brunner TB, Rupp A, Melzner W, Grabenbauer GG, Sauer R. Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518 [Abstract] [Full Text] [Related]
6. External beam and intraluminal radiotherapy in the treatment of carcinoma of the esophagus. Hyden EC, Langholz B, Tilden T, Lam K, Luxton G, Astrahan M, Jepson J, Petrovich Z. J Thorac Cardiovasc Surg; 1988 Aug; 96(2):237-41. PubMed ID: 3398546 [Abstract] [Full Text] [Related]
7. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D. Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546 [Abstract] [Full Text] [Related]
14. [Radiotherapy of esophageal carcinoma: an assessment of patients treated at Tübingen from 1977 to 1982]. Röder HU, Valchera A, Heinsohn C, Schmidt B. Strahlenther Onkol; 1989 Jan 01; 165(1):1-10. PubMed ID: 2916169 [Abstract] [Full Text] [Related]
15. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]. Seitz JF, Milan C, Giovannini M, Dumas F, Cauvin JM, Conroy T, François E, Renard P, Votte-Lambert A, Paillot B, Bedenne L, Fondation Française de Cancérologie Digestive, Groupe Digestif de la Fédération Nationale des Centres de Lutte Contre le Cancer. Gastroenterol Clin Biol; 2000 Feb 01; 24(2):201-10. PubMed ID: 12687962 [Abstract] [Full Text] [Related]
16. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma. Greene FL, Boulware RJ, Bianco J. Surg Laparosc Endosc; 1995 Dec 01; 5(6):425-30. PubMed ID: 8611986 [Abstract] [Full Text] [Related]
18. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207). Gaspar LE, Winter K, Kocha WI, Pinover WH, Herskovic, Graham M, Gunderson L. Cancer J; 2001 Dec 01; 7(5):388-94. PubMed ID: 11693897 [Abstract] [Full Text] [Related]
19. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Jpn J Clin Oncol; 2004 Oct 01; 34(10):615-9. PubMed ID: 15591460 [Abstract] [Full Text] [Related]